InMed Pharmaceuticals GAAP EPS of -$0.73
Source: SeekingAlpha
2026-05-06 18:08:21 ET
More on InMed Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
InMed Pharmaceuticals GAAP EPS of -$0.73
InMed Pharmaceuticals Inc.
NASDAQ: INM
INM Trading
123.81% G/L:
$1.555 Last:
73,877,530 Volume:
$1.79 Open:
INM Latest News
May 19, 2026 10:56:00 am
INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its ShareholdersMay 19, 2026 08:00:00 am
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention TherapiesMay 06, 2026 06:00:00 pm
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
